Abstract:The pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1R) belongs to the secretin receptor family and is widely distributed in the central neural system and peripheral organs. Abnormal activation of the receptor mediates trigeminovascular activation and sensitization, which is highly related to migraine, making PAC1R a potential therapeutic target. Elucidation of PAC1R activation mechanism would benefit discovery of therapeutic drugs for neuronal disorders. PAC1R activity is governed by pituitary adenylate cyclase-activating polypeptide (PACAP), known as a major vasodilator neuropeptide, and maxadilan, a native peptide from the sand fly, which is also capable of activating the receptor with similar potency. These peptide ligands have divergent sequences yet initiate convergent PAC1R activity. It is of interest to understand the mechanism of PAC1R ligand recognition and receptor activity regulation through structural biology. Here we report two near-atomic resolution cryo-EM structures of PAC1R activated by PACAP38 or maxadilan, providing structural insights into two distinct ligand binding modes. The structures illustrate flexibility of the extracellular domain (ECD) for ligands with distinct conformations, where ECD accommodates ligands in different orientations while extracellular loop 1 (ECL1) protrudes to further anchor the ligand bound in the orthosteric site. By structure-guided molecular modeling and mutagenesis, we tested residues in the ligand-binding pockets and identified clusters of residues that are critical for receptor activity. The structures reported here for the first time elucidate the mechanism of specificity and flexibility of ligand recognition and binding for PAC1R, and provide insights toward the design of therapeutic molecules targeting PAC1R.

Cryo-EM structure and biochemical analysis of human chemokine receptor CCR8

Cryo-EM Structure and Biochemical Analysis of the Human Chemokine Receptor CCR8

Unveiling the structural mechanisms of nonpeptide ligand recognition and activation in human chemokine receptor CCR8

Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8

Molecular Insights into Ligand Recognition and Activation of Chemokine Receptors CCR2 and CCR3

Structural insights into the activation of chemokine receptor CXCR2

Structural basis of CXC chemokine receptor 2 activation and signalling

Structural Basis for Chemokine Recognition and Receptor Activation of Chemokine Receptor CCR5.

[Single-Particle Cryo-Electron Microscopy Opens New Avenues in Structural Biology of G Protein-Coupled Receptor].

Identification and mechanism of G protein-biased ligands for chemokine receptor CCR1

Cryo-EM Structures of PAC1 Receptor Reveal Ligand Binding Mechanism

Conformational Transitions and Activation of the Adhesion Receptor CD97.

Activation of the human chemokine receptor CX3CR1 regulated by cholesterol

Structural insights into CXCR4 modulation and oligomerization

Computational Studies of the Binding Modes of Ccr1 Antagonists

Structural analysis of the human C5a-C5aR1 complex using cryo-electron microscopy

Structural basis for CCR6 modulation by allosteric antagonists

Biophysical characterization of the CXC chemokine receptor 2 ligands

Cryo-EM structure of monomeric CXCL12-bound CXCR4 in the active state

Cryo-EM structures of adenosine receptor A3AR bound to selective agonists